SAN ANTONIO, October 20, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, ...
Fort St. John, B.C., residents needing respiratory testing can sigh a breath of relief, with a new diagnostic machine expected to come online soon at the local hospital. A body plethysmograph has now ...
At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With dual training in ENT care and sleep medicine, he offers a well-rounded ...
Hosted on MSN
How Fit Are You? Try the One-Minute Sit-Stand Test
If you’re looking to get some insight into your fitness level, hold off before forking out for a high-tech smart device. The one-minute sit-to-stand test (1MSTS) is a reliable way to assess your ...
Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...
The city's dry weather, chilly nights, and hot daytime temperatures have led to a rapid increase in patients suffering from asthma, allergies, fever, and respiratory illnesses. According to medical ...
For many RNLD’s in general practice, annual health checks are core to the care they offer. However, only just over a quarter (26%) of people with a learning disability are on the learning disability ...
Angina, a symptom of underlying heart disease, is frequently overlooked in women despite being a leading cause of death. Unlike men, women often experience atypical symptoms, leading to misdiagnosis a ...
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
Rep. Cynthia Roe (R-Lindsay) hosted an interim study Thursday exploring policy solutions related to lung cancer prevention, treatment and health equity.
12hon MSN
Teclistamab T-cell therapy shows promise in patients with drug-resistant autoimmune disease
Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic benefit for patients with severe forms of treatment-resistant autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results